May 24 (Reuters) - Johnson & Johnson has agreed to pay $33 million to resolve prices by most U.S. Tylenol, Motrin, Benadryl and other over-the-counter medicine that have been ultimately recalled. The record contains St. Joseph Aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec, and Zyrtec Eye Drops, the Illinois lawyer general stated in a news launch. The company's Johnson & Johnson Client Inc unit must additionally be certain that its advertising and promotional practices do not unlawfully promote over-the-counter drug products, the attorneys normal mentioned. The accord adopted a string of recalls of millions of packages of medication made by J&J's McNeil-PPC Inc unit, now part of Johnson & Johnson Shopper, over defective manufacturing. In response to the state attorneys basic, McNeil put on the market batches of medication that didn't adjust to federal requirements and had been deemed adulterated as a matter of federal law. They claimed that McNeil misrepresented its compliance federal manufacturing rules. The standard of its over-the-counter medicine. Illinois Attorney General Lisa Madigan mentioned in an announcement. J&J's McNeil unit previously in 2015 pleaded responsible to selling liquid drugs contaminated with metallic and agreed to pay $25 million to resolve a U.S. Flucoxin